CoChat
Sign Up
Cited by 110Health Systems, Economic Evaluations, Quality of LifeMental Health Treatment and AccessAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders

ISSAKIDIS, C., SANDERSON, K., CORRY, J., ANDREWS, G., LAPSLEY, H.·2004·Psychological Medicine
DOI 10.1017/s003329170300881x
Open this paper in CoChat — free account

Abstract

BACKGROUND: The present paper describes a component of a large population cost-effectiveness study that aimed to identify the averted burden and economic efficiency of current and optimal treatment for the major mental disorders. This paper reports on the findings for the anxiety disorders (panic disorder/agoraphobia, social phobia, generalized anxiety disorder, post-traumatic stress disorder and obsessive compulsive disorder). METHOD: Outcome was calculated as averted 'years lived with disability' (YLD), a population summary measure of disability burden. Costs were the direct health care costs in 1997-8 Australian dollars. The cost per YLD averted (efficiency) was calculated for those already in contact with the health system for a mental health problem (current care) and for a hypothetical optimal care package of evidence-based treatment for this same group. Data sources included the Australian National Survey of Mental Health and Well-being and published treatment effects and unit costs. RESULTS: Current coverage was around 40% for most disorders with the exception of social phobia at 21%. Receipt of interventions consistent with evidence-based care ranged from 32% of those in contact with services for social phobia to 64% for post-traumatic stress disorder. The cost of this care was estimated at dollar 400 million, resulting in a cost per YLD averted ranging from dollar 7761 for generalized anxiety disorder to dollar 34 389 for panic/agoraphobia. Under optimal care, costs remained similar but health gains were increased substantially, reducing the cost per YLD to < dollar 20 000 for all disorders. CONCLUSIONS: Evidence-based care for anxiety disorders would produce greater population health gain at a similar cost to that of current care, resulting in a substantial increase in the cost-effectiveness of treatment.

Overview

Integrity signals

Registry

Crossref · 10.1017/s003329170300881x

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 37 references

Cited by

Sorted by citations

Items 101–110 of 110

Related

See all

Metadata

Authors
ISSAKIDIS, C., SANDERSON, K., CORRY, J., ANDREWS, G., & LAPSLEY, H.
Affiliations
UNSW Sydney (AU)
ORCID
Venue
Psychological Medicine
Publisher
Cambridge University Press (CUP)
Published
2004-01
Volume
34
Issue
1
Pages
19-35
ISSN
  • 0033-2917 (ISSN-L)
  • 1469-8978
DOI
10.1017/s003329170300881x
OpenAlex
W2036167557
Cited by
110
References
37
Citations by year
2025: 1 · 2024: 2 · 2023: 3 · 2021: 10 · 2020: 1 · 2019: 3 · 2018: 5 · 2017: 1 · 2016: 5 · 2015: 3 · 2014: 8 · 2013: 4 · 2012: 9
FWCI
26.21
Type
journal article
Language
en
Open access
closed
Licence
www.cambridge.org/core/terms (unspecified, 13 d)
Locations
  • Psychological Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • eCite Digital Repository (University of Tasmania) (submittedVersion)
  • Figshare (submittedVersion)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
anxiety disorders, cost-effectiveness, evidence-based treatment, years lived with disability, disability burden, generalized anxiety disorder, panic disorder, agoraphobia, social anxiety disorder, post-traumatic stress disorder, obsessive-compulsive disorder, treatment costs
MeSH terms
Anxiety Disorders, Australia, Cost-Benefit Analysis, Humans, Mental Health Services, Monte Carlo Method, Anti-Anxiety Agents, Cognitive Behavioral Therapy, Health Care Costs, Models, Econometric, Cost of Illness, Quality-Adjusted Life Years, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review